| Lenvatinib versus placebo in radioiodine-refractory thyroid cancer M Schlumberger, M Tahara, LJ Wirth, B Robinson, MS Brose, R Elisei, ... New England Journal of Medicine 372 (7), 621-630, 2015 | 2143 | 2015 |
| Comprehensive pan-genomic characterization of adrenocortical carcinoma S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ... Cancer cell 29 (5), 723-736, 2016 | 689 | 2016 |
| Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as … M Ayala-Ramirez, L Feng, MM Johnson, S Ejaz, MA Habra, T Rich, ... The Journal of Clinical Endocrinology & Metabolism 96 (3), 717-725, 2011 | 468 | 2011 |
| Parathyroid carcinoma: a 22‐year experience NL Busaidy, C Jimenez, MA Habra, PN Schultz, AK El‐Naggar, ... Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2004 | 370 | 2004 |
| Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center M Ayala-Ramirez, S Jasim, L Feng, S Ejaz, F Deniz, N Busaidy, ... European journal of endocrinology 169 (6), 891-899, 2013 | 310 | 2013 |
| Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas M Ayala-Ramirez, CN Chougnet, MA Habra, JL Palmer, S Leboulleux, ... The Journal of Clinical Endocrinology & Metabolism 97 (11), 4040-4050, 2012 | 239 | 2012 |
| Salvage pembrolizumab added to kinase inhibitor therapy for the treatment of anaplastic thyroid carcinoma PC Iyer, R Dadu, M Gule-Monroe, NL Busaidy, R Ferrarotto, MA Habra, ... Journal for immunotherapy of cancer 6, 1-10, 2018 | 219 | 2018 |
| Cushing syndrome secondary to ectopic adrenocorticotropic hormone secretion: the University of Texas MD Anderson Cancer Center Experience S Ejaz, R Vassilopoulou‐Sellin, NL Busaidy, MI Hu, SG Waguespack, ... Cancer 117 (19), 4381-4389, 2011 | 203 | 2011 |
| Current and future treatments for malignant pheochromocytoma and sympathetic paraganglioma C Jimenez, E Rohren, MA Habra, T Rich, P Jimenez, M Ayala-Ramirez, ... Current oncology reports 15, 356-371, 2013 | 195 | 2013 |
| Lenvatinib: Role in thyroid cancer and other solid tumors ME Cabanillas, MA Habra Cancer treatment reviews 42, 47-55, 2016 | 191 | 2016 |
| Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra‐adrenal paragangliomas: insights from the largest single … M Ayala‐Ramirez, L Feng, MA Habra, T Rich, PV Dickson, N Perrier, ... Cancer 118 (11), 2804-2812, 2012 | 176 | 2012 |
| Insulin growth factor receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with metastatic adrenocortical carcinoma A Naing, P Lorusso, S Fu, D Hong, HX Chen, LA Doyle, AT Phan, ... British journal of cancer 108 (4), 826-830, 2013 | 159 | 2013 |
| Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma MA Habra, B Stephen, M Campbell, K Hess, C Tapia, M Xu, ... Journal for immunotherapy of cancer 7, 1-9, 2019 | 147 | 2019 |
| Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma E Baudin, MA Habra, F Deschamps, G Cote, F Dumont, M Cabanillas, ... European journal of endocrinology 171 (3), R111-R122, 2014 | 147 | 2014 |
| Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? AB Cooper, MA Habra, EG Grubbs, BK Bednarski, AK Ying, ND Perrier, ... Surgical endoscopy 27, 4026-4032, 2013 | 141 | 2013 |
| Phase 2 study of pembrolizumab in patients with advanced rare cancers A Naing, F Meric-Bernstam, B Stephen, DD Karp, J Hajjar, JR Ahnert, ... Journal for immunotherapy of cancer 8 (1), e000347, 2020 | 140 | 2020 |
| Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma M Ayala-Ramirez, JL Palmer, MC Hofmann, M De La Cruz, BS Moon, ... The Journal of Clinical Endocrinology & Metabolism 98 (4), 1492-1497, 2013 | 137 | 2013 |
| Efficacy and Tolerability of Vemurafenib in Patients with BRAFV600E -Positive Papillary Thyroid Cancer: M.D. Anderson Cancer Center Off Label Experience R Dadu, K Shah, NL Busaidy, SG Waguespack, MA Habra, AK Ying, ... The Journal of Clinical Endocrinology & Metabolism 100 (1), E77-E81, 2015 | 134 | 2015 |
| A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma MA Habra, S Ejaz, L Feng, P Das, F Deniz, EG Grubbs, A Phan, ... The Journal of Clinical Endocrinology & Metabolism 98 (1), 192-197, 2013 | 128 | 2013 |
| Real-world experience with targeted therapy for the treatment of anaplastic thyroid carcinoma PC Iyer, R Dadu, R Ferrarotto, NL Busaidy, MA Habra, M Zafereo, N Gross, ... Thyroid 28 (1), 79-87, 2018 | 125 | 2018 |
